Cole Mullis

Cole Mullis serves as a procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of critical scientific and operational capabilities. He manages a diverse portfolio of contracts focused on laboratory diagnostics, biomedical research tools, and data infrastructure essential for disease surveillance and rapid public health response. His work ensures timely access to high-performance analytical instruments, clinical testing platforms, and informatics systems that underpin CDC’s national health security initiatives. Mullis operates within federal acquisition regulations to align procurement decisions with agency priorities in infectious disease detection and laboratory capacity building. He maintains sustained relationships with key industry partners including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, and Cepheid, reflecting a preference for established vendors with proven expertise in diagnostic technology, biomedical research support, and public health informatics. His contracting patterns emphasize performance-based outcomes and technical reliability, often engaging contractors with deep domain knowledge in clinical diagnostics and epidemiological data systems. These partnerships are typically structured as indefinite-delivery/indefinite-quantity (IDIQ) or cost-reimbursement contracts to accommodate the dynamic nature of public health emergencies. Mullis demonstrates a strong commitment to small business participation, with approximately 25% of his acquisitions set aside for total small business concerns under FAR 19.5. While the majority of awards are unrestricted, he consistently prioritizes socioeconomic programs that expand access for small and emerging firms in the life sciences and IT sectors, ensuring broad vendor competition and innovation. His primary NAICS focus areas include analytical laboratory instrument manufacturing (334516), custom computer programming services (541511), and information services (519290), reflecting expertise in procuring advanced diagnostic equipment, laboratory information management systems, and real-time data analytics platforms. He specializes in acquiring technologies that enhance molecular testing, genomic sequencing, and public health surveillance infrastructure.